Continue to meet or exceed healthcare partners’ expectations by providing on-time test results approximately 92 percent of the time.
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...